We are live on ! Find out more
FAF

Fjarde Ap-fonden Portfolio holdings

AUM $20.9B
1-Year Est. Return 36.93%
This Fund
S&P 500
This Quarter Est. Return
+13.26%
1 Year Est. Return
+36.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.04B
AUM Growth
+$1.05B
Cap. Flow
+$233M
Cap. Flow %
2.57%
Top 10 Hldgs %
27.58%
Holding
558
New
7
Increased
354
Reduced
164
Closed
23

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$14.4M
2
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$10M
3
AMZN icon
Amazon
AMZN
+$9.4M
4
ECL icon
Ecolab
ECL
+$8.33M
5
NVDA icon
NVIDIA
NVDA
+$8.31M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$20.7M
2
DD icon
DuPont de Nemours
DD
+$8.16M
3
CTVA icon
Corteva
CTVA
+$7.32M
4
SPLK
Splunk Inc
SPLK
+$5.38M
5
AWK icon
American Water Works
AWK
+$5.35M

Sector Composition

Rank Sector Weight
1 Technology 31.3%
2 Healthcare 14.55%
3 Financials 14.11%
4 Consumer Discretionary 10.28%
5 Communication Services 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
51
Abbott
ABT
$177B
$31.7M 0.35%
278,788
+9,000
+3% +$1.03M
BKR icon
52
Baker Hughes
BKR
$56.3B
$31.7M 0.35%
945,689
+144,100
+18% +$4.44M
MDT icon
53
Medtronic
MDT
$120B
$30.9M 0.34%
354,379
+4,900
+1% +$418K
GE icon
54
GE Aerospace
GE
$319B
$30.7M 0.34%
219,356
+6,265
+3% +$738K
INTC icon
55
Intel
INTC
$513B
$30.2M 0.33%
684,311
+24,300
+4% +$1.08M
DHR icon
56
Danaher
DHR
$147B
$30.2M 0.33%
120,972
+3,600
+3% +$879K
VRTX icon
57
Vertex Pharmaceuticals
VRTX
$130B
$29.7M 0.33%
70,988
+2,000
+3% +$845K
MRSH
58
Marsh
MRSH
$85.8B
$29.5M 0.33%
143,431
+728
+0.5% +$145K
ROP icon
59
Roper Technologies
ROP
$38B
$29.4M 0.33%
52,498
+3,300
+7% +$1.8M
PGR icon
60
Progressive
PGR
$129B
$28.7M 0.32%
138,770
+4,700
+4% +$872K
TJX icon
61
TJX Companies
TJX
$137B
$28M 0.31%
276,368
+7,169
+3% +$695K
BMY icon
62
Bristol-Myers Squibb
BMY
$130B
$27.6M 0.31%
509,506
+16,000
+3% +$815K
UBER icon
63
Uber
UBER
$146B
$27.5M 0.3%
357,183
+115,600
+48% +$8.3M
LRCX icon
64
Lam Research
LRCX
$339B
$27M 0.3%
278,260
-1,000
-0.4% -$88K
ISRG icon
65
Intuitive Surgical
ISRG
$133B
$26.6M 0.29%
66,579
+300
+0.5% +$113K
CVS icon
66
CVS Health
CVS
$121B
$26.5M 0.29%
332,419
+12,400
+4% +$947K
LOW icon
67
Lowe's Companies
LOW
$109B
$26.3M 0.29%
103,405
+3,900
+4% +$897K
EIX icon
68
Edison International
EIX
$21B
$26.2M 0.29%
370,097
+5,825
+2% +$398K
CB icon
69
Chubb
CB
$132B
$26.1M 0.29%
100,564
+2,600
+3% +$639K
NOW icon
70
ServiceNow
NOW
$147B
$25.9M 0.29%
169,780
+7,000
+4% +$1.06M
GILD icon
71
Gilead Sciences
GILD
$181B
$25.7M 0.28%
350,363
+14,300
+4% +$1.1M
REGN icon
72
Regeneron Pharmaceuticals
REGN
$79.7B
$25.5M 0.28%
26,452
+300
+1% +$285K
T icon
73
AT&T
T
$183B
$25.4M 0.28%
1,445,170
+127,700
+10% +$2.18M
ADP icon
74
Automatic Data Processing
ADP
$110B
$25.4M 0.28%
101,517
+6,031
+6% +$1.47M
ELV icon
75
Elevance Health
ELV
$90.6B
$25.3M 0.28%
48,712
+3,400
+8% +$1.69M

Similar funds

Fjarde Ap-fonden's Q1 2024 Portfolio in Review

As of Q1 2024, Fjarde Ap-fonden held 558 positions worth $9.04B, up 13% from $7.99B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Fjarde Ap-fonden's Q1 2024 filing shows 7 new, 354 increased, 164 reduced and 23 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 200,000 shares worth $10.3M. The largest sale was Apple, an estimated $20.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.

  • Fjarde Ap-fonden's largest Q1 2024 buy was iShares Core MSCI Emerging Markets ETF: 200,000 shares worth $10.3M.
  • Fjarde Ap-fonden added most to Microsoft in Q1 2024, an estimated $14.4M increase.
  • Fjarde Ap-fonden's biggest Q1 2024 reduction was Apple, cutting an estimated $20.7M.
  • Fjarde Ap-fonden fully exited Splunk Inc in Q1 2024, selling an estimated $5.38M.
  • Fjarde Ap-fonden's ten largest holdings make up 28% of its $9.04B portfolio in Q1 2024.
  • Fjarde Ap-fonden opened 7 new positions and closed 23 in Q1 2024.
  • Fjarde Ap-fonden's portfolio value rose 13% quarter-over-quarter to $9.04B.

Based on Fjarde Ap-fonden's 13F filing for Q1 2024, filed 25 Apr 2024.